Huaxi Biologics China Life Chengda, a subsidiary of Chinese Life, intends to reduce its stake in the company by no more than 2.5. - Yicai Global
| 688099 Stock | 74.20 4.18 5.33% |
About 61% of Amlogic Shanghai's investor base is looking to short. The analysis of overall sentiment of trading Amlogic Shanghai Co stock suggests that many investors are alarmed at this time. The current market sentiment, together with Amlogic Shanghai's historical and current headlines, can help investors time the market. In addition, many technical investors use Amlogic Shanghai stock news signals to limit their universe of possible portfolio assets.
Amlogic |
Huaxi Biologics China Life Chengda, a subsidiary of Chinese Life, intends to reduce its stake in the company by no more than 2.5. Yicai Global
Read at news.google.com
 |
Amlogic Shanghai Fundamental Analysis
We analyze Amlogic Shanghai's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amlogic Shanghai using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amlogic Shanghai based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Amlogic Shanghai is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Amlogic Shanghai Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amlogic Shanghai stock to make a market-neutral strategy. Peer analysis of Amlogic Shanghai could also be used in its relative valuation, which is a method of valuing Amlogic Shanghai by comparing valuation metrics with similar companies.
Peers
Amlogic Shanghai Related Equities
| 002096 | Hunan Nanling | 0.84 |
| ||
| 601615 | Ming Yang | 1.47 |
| ||
| 300729 | Loctek Ergonomic | 4.21 |
| ||
| 002952 | Yes Optoelectronics | 5.47 |
| ||
| 300243 | Shandong Ruifeng | 5.67 |
| ||
| 002999 | Guangdong Tianhe | 6.04 |
| ||
| 603269 | Jiangsu Seagull | 6.35 |
|
Complementary Tools for Amlogic Stock analysis
When running Amlogic Shanghai's price analysis, check to measure Amlogic Shanghai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amlogic Shanghai is operating at the current time. Most of Amlogic Shanghai's value examination focuses on studying past and present price action to predict the probability of Amlogic Shanghai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amlogic Shanghai's price. Additionally, you may evaluate how the addition of Amlogic Shanghai to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |